Package 45802-053-02

{"route": ["TOPICAL"], "spl_id": "af10e709-e348-420b-aa9b-154c15cc5df3", "openfda": {"unii": ["9IFA5XM7R2"], "rxcui": ["1244634"], "spl_set_id": ["dc5dfd3e-7762-40c8-880e-c7db80d87749"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CAN in 1 CARTON (45802-053-01)  / 50 g in 1 CAN", "package_ndc": "45802-053-01", "marketing_start_date": "20130115"}, {"sample": false, "description": "1 CAN in 1 CARTON (45802-053-02)  / 100 g in 1 CAN", "package_ndc": "45802-053-02", "marketing_start_date": "20130115"}], "brand_name": "Betamethasone Valerate", "product_id": "45802-053_af10e709-e348-420b-aa9b-154c15cc5df3", "dosage_form": "AEROSOL, FOAM", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "45802-053", "generic_name": "Betamethasone Valerate", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Betamethasone Valerate", "active_ingredients": [{"name": "BETAMETHASONE VALERATE", "strength": "1.2 mg/g"}], "application_number": "ANDA078337", "marketing_category": "ANDA", "marketing_start_date": "20130115", "listing_expiration_date": "20261231"}